|
|
|
| Consensus and disputes on the adjuvant therapy for non-small cell lung cancer with positive surgical margins |
| Yuan Meng1, Men Yu2, Kang Jingjing1, Sun Xin1, Zhao Maoyuan1, Yang Xu1, Bao Yongxing1, Hui Zhouguang2 |
1Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;
2Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China |
|
[1] Hancock JG, Rosen JE, Antonicelli A, et al. Impact of adjuvant treatment for microscopic residual disease after non-small cell lung cancer surgery[J]. Ann Thorac Surg, 2015, 99(2):406-413. DOI:10.1016/j.athoracsur.2014.09.033.
[2] Wind J, Smit EJ, Senan S, et al. Residual disease at the bronchial stump after curative resection for lung cancer[J]. Eur J Cardiothorac Surg, 2007, 32(1):29-34. DOI:10.1016/j.ejcts.2007.04.003.
[3] Riquet M, Achour K, Foucault C, et al. Microscopic residual disease after resection for lung cancer:a multifaceted but poor factor of prognosis[J]. Ann Thorac Surg, 2010, 89(3):870-875. DOI:10.1016/j.athoracsur.2009.11.052.
[4] Ohguri T, Yahara K, Moon SD, et al. Postoperative radiotherapy for incompletely resected nonsmall cell lung cancer:Clinical outcomes and prognostic value of the histological subtype[J]. J Radiat Res, 2012(53):319-325. DOI:10.1269/jrr.11082.
[5] Osarogiagbon RU, Lin CC, Smeltzer MP, et al. Prevalence, prognostic implications, and survival modulators of incompletely resected non-small cell lung cancer in the U. S. National Cancer Data Base[J]. J Thorac Oncol, 2016, 11(1):e5-16. DOI:10.1016/j.jtho.2015.08.002.
[6] 邓勇军, 杨鸿生, 施云飞, 等. 肺癌术后支气管切缘癌发生的相关因素分析[J]. 实用癌症杂志, 2003, 18(6):627-629. DOI:10.3969/j.issn.1001-5930.2003.06.024.
Deng YJ, Yang HS, Shi YF, et al. Risk factors for the residual carcinoma on the bronchial margin after radical resection of lung cancer[J]. Practic J Cancer, 2003, 18(6):627-629. DOI:10.3969/j.issn.1001-5930.2003.06.024.
[7] Snijder RJ, Brutel de la Rivière A, Elbers HJ, et al. Survival in resected stage Ⅰ lung cancer with residual tumor at the bronchial resection margin[J]. Ann Thorac Surg, 1998, 65(1):212-216. DOI:10.1016/s0003-4975(97)01114-4.
[8] Ghiribelli C, Voltolini L, Paladini P, et al. Treatment and survival after lung resection for non-small cell lung cancer in patients with microscopic residual disease at the bronchial stump[J]. Eur J Cardiothorac Surg, 1999, 16(5):555-559. DOI:10.1016/S1010-7940%2899%2900310-3.
[9] Hofmann HS, Taege C, Lautenschläger C, et al. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer[J]. Eur J Cardiothorac Surg, 2002, 21(4):606-610. DOI:10.1016/S1010-7940(02)00030-1.
[10] Little AG, Rusch VW, Bonner JA, et al. Patterns of surgical care of lung cancer patients[J]. Ann Thorac Surg, 2005, 80(6):2051-2056. DOI:10.1016/j.athoracsur.2005.06.071.
[11] Lyu J, Hao X, Hui Z, et al. Prognosis of R1-resection at the bronchial stump in patients with non-small cell lung cancer[J]. Chin Med J (Engl), 2014, 127(16):2918-2923. DOI:10.3760/cma.j.issn.0366-6999.20140980.
[12] Smeltzer MP, Lin CC, Kong FS, et al. Survival impact of postoperative therapy modalities according to margin status in non-small cell lung cancer patients in the United States[J]. J Thorac Cardiovasc Surg, 2017, 154(2):661-672 e10. DOI:10.1016/j.jtcvs.2017.03.085.
[13] 陈跃军, 欧阳立志, 肖高明, 等. 肺癌术后支气管切缘癌阳性 40例临床分析[J]. 医学临床研究, 2004, 21(8):914-915. DOI:10.3969/j.issn.1671-7171.2004.08.033.
Chen YJ, Ouyang LZ, Xiao GM, et al. Clinical analysis of 40 cases of positive bronchial margin after lung cancer surgery[J]. J Clin Res, 2004, 21(8):914-915. DOI:10.3969/j.issn.1671-7171.2004.08.033.
[14] Ohguri T, Yahara K, Moon SD, et al. Postoperative radiotherapy for incompletely resected non-small cell lung cancer:clinical outcomes and prognostic value of the histological subtype[J]. J Radiat Res, 2012, 53(2):319-325. DOI:10.1269/jrr.11082.
[15] 胡小波, 王研, 崔有斌, 等. 非小细胞肺癌术后支气管切缘癌对预后的影响[J]. 吉林医学, 2005, 26(12):1282-1284. DOI:10.3969/j.issn.1004-0412.2005.12.012.
Hu XB, Wang Y, Cui YB, et al. Study of residual tumor on the bronchial margin after resection for non-small cell carcinoma of the lung[J]. Jilin Medical J, 2005, 26(12):1282-1284. DOI:10.3969/j.issn.1004-0412.2005.12.012.
[16] 卢喜科, 王嵩, 田铁栓. 非小细胞肺癌术后支气管切缘癌与预后[J]. 中华胸心血管外科杂志, 1998, 14(3):158-160. DOI:10.3760/cma.j.issn.1001-4497.1998.03.010.
Lu XK, Wang S, Tian TS. Study of residual tumor on the bronchial margin after resection for non-small cell carcinoma of the lung[J]. Chin J Thorac Cardiovasc Surg, 1998, 14(3):158-160. DOI:10.3760/cma.j.issn.1001-4497.1998.03.010.
[17] 王圆,王长利,岳东升. 支气管残端阳性非小细胞肺癌的预后分析[J]. 实用癌症杂志, 2009, 24(2):153-155,161. DOI:10.3969/j.issn.1001-5930.2009.02.014.
Wang Y, Wang CL, Yue DL. Prognostic analyses of non-small cell lung cancer with residual disease at the bronchial resection margin[J]. Practic J Cancer, 2009, 24(2):153-155,161. DOI:10.3969/j.issn.1001-5930.2009.02.014.
[18] 吴一龙, 黄植蕃, 戎铁华, 等. 非小细胞肺癌术后支气管残端阳性对预后的影响[J]. 肿瘤, 1997(4):16-18.
Wu YL, Huang ZF, Rong TH, et al. Influence of cancer residue in bronchial stump on the prognosis of non-small cell lung cancer patients[J]. Tumor, 1997(4):16-18.
[19] 马千里, 刘德若, 郭永庆, 等. 非小细胞肺癌袖式肺叶切除后切缘阳性的意义[J]. 中日友好医院学报, 2015, 29(3):135-138. DOI:10.3969/j.issn.1001-0025.2015.03.002.
Ma QL, Liu RD, Guo YQ, et al. Significance of the positive residual disease for non-small cell lung cancer after bronchial sleeve resection[J]. J China-Japan Friendship Hospital, 2015, 29(3):135-138. DOI:10.3969/j.issn.1001-0025.2015.03.002.
[20] 邓垒, 惠周光, 门玉, 等. 术前临床因素预测pⅢA-N2非小细胞肺癌术后放疗获益人群的研究[J]. 国际放射医学核医学杂志, 2018, 42(3):224-232. DOI:10.3760/cma.j.issn.1673-4114.2018.03.006.
Deng L, Hui ZG, Men Y, et al. Preoperative clinical risk factors in selecting patients with pathological ⅢA-N2 non-small-cell lung cancer benefiting from postoperative radiotherapy[J]. Int J Radiat Med Nucl Med, 2018, 42(3):224-232. DOI:10.3760/cma.j.issn.1673-4114.2018.03.006.
[21] Wang EH, Corso C, Rutter CE, et al. Postoperative radiation therapy is associated with improved overall survival in incompletely resected stage Ⅱ and Ⅲ non-small-cell lung cancer[J]. J Clin Oncol, 2015, 33(25):2727-2734. DOI:10.1016/j.ijrobp.2015.07.1538.
[22] Rieber J, Alexander D, Elena U, et al. Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC)[J]. Lung Cancer, 2016, 91:41-47. DOI:10.1016/j.lungcan.2015.11.014.
[23] Lee GD, Kim DK, Jang SJ, et al. Significance of R1-resection at the bronchial margin after surgery for non-small-cell lung cancer[J]. Eur J Cardiothorac Surg, 2017, 51(1):176-181. DOI:10.1093/ejcts/ezw242.
[24] Park J, Song S, Kim S, et al. Postoperative radiation therapy following the incomplete resection of a non-small cell lung cancer[J]. Radiat Oncol J, 2014, 32(2):70-76. DOI:10.3857/roj.2014.32.2.70.
[25] Zhou M, Li T, Liu Y, et al. Concurrent paclitaxel-based chemo-radiotherapy for post-surgical microscopic residual tumor at the bronchial margin (R1 resection) in non-small-cell lung cancer[J]. BMC Cancer, 2015, 15:36. DOI:10.1186/s12885-015-1036-0.
[26] Hui Z, Dai H, Liang J, et al. Selection of proper candidates with resected pathological stage ⅢA-N2 non-small cell lung cancer for postoperative radiotherapy[J]. Thorac Cancer, 2015, 6(3):346-353. DOI:10.1111/1759-7714.12186.
[27] Corso CD, Rutter CE, Wilson LD, et al. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database[J]. J Thorac Oncol, 2015, 10(1):148-155. DOI:10.1097/JTO.0000000000000406.
[28] Douillard JY, Rosell R, Lena MD, et al. Impact of postoperative radiation therapy on survival in patients with complete resection and stage Ⅰ, Ⅱ, or ⅢA non-small-cell lung cancer treated with adjuvant chemotherapy:the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial[J]. Int J Radiat Oncol Biol Phys, 2008, 72(3):695-701. DOI:10.1016/j.ijrobp.2008.01.044.
[29] Maygarden SJ, Detterbeck FC, Funkhouser WK. Bronchial margins in lung cancer resection specimens:utility of frozen section and gross evaluation[J]. Mod Pathol, 2004, 17(9):1080-1086. DOI:10.1038/modpathol.3800154.
[30] Strauss GM, Herndon JE, Maddaus MA, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage ⅠB non-small-cell lung cancer:CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups[J]. J Clin Oncol, 2008(26):5043–5051. DOI:10.1200/JCO.2008.16.4855.
[31] Ghiribelli C, Voltolini L, Paladini P, et al. Treatment and survival after lung resection for nonsmall cell lung cancer in patients with microscopic residual disease at the bronchial stump[J]. Eur J Cardiothorac Surg, 1999, 16(5):555–559. DOI:10.1016/S1010-7940%2899%2900310-3.
[32] Hofmann HS, Taege C, Lautenschläger C, et al. Microscopic (R1) and macroscopic (R2) residual disease in patients with resected non-small cell lung cancer[J]. Eur J Cardiothorac Surg, 2002, 21(4):606-610. DOI:10.1016/S1010-7940(02)00030-1.
[33] Balasubramanian S, Au J, Dunning J. Should lobectomy patients with microscopic involvement of the bronchial resection margin undergo re-operation to improve their long-term survival?[J]. Interact Cardiovasc Thorac Surg, 2005, 4(6):531-537. DOI:10.1510/icvts.2005.114702.
[34] Francis S, Orton A, Stoddard G, et al. Sequencing of postoperative radiotherapy and chemotherapy for locally advanced or incompletely resected non–small-cell lung cancer[J]. J Clin Oncol, 2018, 36(4):333-341. DOI:10.1200/jco.2017.74.4771.
[35] Smeltzer MP, Lin CC, Kong FS, et al. Survival impact of post-operative therapy modalities after incomplete and complete surgical resection for non-small cell lung cancer in the US[C]// 16th World Conference on Lung Cancer. Denver, 2015. |
|
|
|
2020, Vol. 29 
